Sales & Marketing Sponsored Servier reveal how they are using data to empower their fiel... The French independent pharmaceutical Servier is putting data at the foundation of its customer relationship management strategy.
News France's Servier finally goes on trial over Mediator safety ... More than a decade after a scandal over drug safety in France first broke, the pharma company Servier is to go on trial over its weight loss drug Mediator, which is thought to have caused b
News Servier and Oncodesign announce Parkinson's R&D tie-up Servier and Oncodesign have announced a strategic partnership for R&D into potential drug candidates for Parkinson’s disease.
News Servier expands global footprint post Shire deal Following its acquisition of Shire’s oncology business in April, Servier is taking steps to expand its presence in the US and China.
News Shire's $2.4bn oncology sell-off seen as Takeda spoiler Move seen as attempt to fend off Takeda takeover
News Safety restrictions spell the end for Servier osteoporosis d... Sales of Protelos hit by safety restrictions.
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends